Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$13.90
-0.0100 (-0.0719%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $12.20 $16.47 Friday, 10th May 2024 VRDN stock ended at $13.90. This is 0.0719% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 5.32% from a day low at $13.34 to a day high of $14.05.
90 days $12.20 $21.42
52 weeks $10.93 $28.35

Historical Viridian Therapeutics, Inc. prices

Date Open High Low Close Volume
Apr 30, 2019 $45.90 $46.65 $43.20 $43.95 13 216
Apr 29, 2019 $46.20 $47.40 $43.80 $45.98 23 312
Apr 26, 2019 $43.95 $47.10 $41.55 $44.40 29 036
Apr 25, 2019 $42.30 $43.05 $41.10 $41.40 4 484
Apr 24, 2019 $44.10 $44.85 $42.15 $42.45 6 512
Apr 23, 2019 $40.95 $44.70 $40.95 $43.80 7 936
Apr 22, 2019 $40.80 $42.45 $40.65 $40.95 6 700
Apr 18, 2019 $42.30 $42.90 $40.80 $40.95 11 396
Apr 17, 2019 $44.55 $44.55 $40.95 $42.45 14 348
Apr 16, 2019 $45.00 $45.75 $42.60 $43.50 14 340
Apr 15, 2019 $44.40 $45.00 $42.00 $44.55 15 322
Apr 12, 2019 $45.60 $46.65 $43.20 $44.40 7 875
Apr 11, 2019 $46.35 $46.35 $43.80 $45.00 9 103
Apr 10, 2019 $46.65 $47.25 $45.00 $45.90 5 476
Apr 09, 2019 $46.80 $47.85 $45.30 $46.20 10 695
Apr 08, 2019 $46.80 $48.30 $45.60 $46.95 11 535
Apr 05, 2019 $47.55 $48.90 $45.45 $46.80 10 483
Apr 04, 2019 $45.00 $47.85 $44.40 $47.40 8 854
Apr 03, 2019 $44.25 $46.50 $43.95 $44.85 12 461
Apr 02, 2019 $43.20 $44.70 $42.45 $43.95 10 350
Apr 01, 2019 $42.00 $43.65 $40.95 $43.05 10 969
Mar 29, 2019 $42.45 $44.10 $41.55 $41.85 8 312
Mar 28, 2019 $43.20 $43.55 $41.40 $42.15 6 709
Mar 27, 2019 $42.00 $43.80 $40.05 $43.05 29 586
Mar 26, 2019 $44.85 $46.35 $42.15 $42.30 14 108
Click to get the best stock tips daily for free!

About Viridian Therapeutics, Inc.

Viridian Therapeutics. Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-003, a therapeutic antibody targeting IGF-1R for the treatment of TED. The company was formerly known as ... VRDN Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT